Skip to main content
. Author manuscript; available in PMC: 2016 Dec 1.
Published in final edited form as: Biol Blood Marrow Transplant. 2015 Jul 26;21(12):2136–2140. doi: 10.1016/j.bbmt.2015.07.018

Table 3.

Adverse Events

Adverse Events Grade
1
Grade
2
Grade
3
Grade
4
Hematological AEs
Anemia 16% 3%
Neutropenia 11% 5%
Thrombocytopenia 8%
Lymphopenia 3% 3% 3%
Non-Hematological AEs
Peripheral neuropathy 49% 3%
AST elevation 32% 5% 3%
ALT elevation 27% 11%
Rash (new) 24% 11% 5%
Muscle weakness 24% 5%
Hypoglycemia 22%
Fatigue 19% 11%
Pruritis 19% 3% 3%
Nausea 16% 3%
Abdominal Pain 11% 5%
Creatinine elevated 3%
Tumor lysis syndrome 3%
Hyperuricemia 3%